Accordingly, small molecule ACKR3 agonists have been widely used to probe its scavenging function, showing efficacy in various cancer models,2,3,15,17,20 whereas inhibition of ACKR3 activity remains underexplored. The gene discussed is ACKR3; the disease is cancer.